ghrelin and glp-1 Glucagon-Like Peptide-1: A Gut-Brain Axis Battle for Food Reward Gut hormones and their supposed

The efficacy and safety of -nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial

In a recent post, Geoff Cook , founder of NOOM, echoed this theme: If a life-saving drug costs 510x more in the US

If 0.25 mg makes you nauseous, they can officially prescribe 0.1 mg, something a standard pharmacy cannot do

The combination of declining estrogen, changing androgen ratios, and the metabolic stress of weight loss creates a perfect storm for follicular disruption

[5] Real-world adherence data reinforce the problem

Berntson GG, Zipf WB, O'Dorisio TM, Hoffman JA, Chance RE